对Gremlin-1的新见解:瘤微环境的景观重新设计和潜在的治疗点
Chengpeng Sun1, Zijun Ding2, Benjie Li3
1Department of General Surgery, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, 1 Minde Road, Nanchang 330006, China; HuanKui Academy, Nanchang University, Nanchang 330006, Jiangxi Province, China.
Biochimica et biophysica acta. Molecular cell research
|April 18, 2025
概括
格雷姆林-1 (GREM1) 是一种蛋白质对抗剂,通过影响瘤微环境 (TME) 在瘤中发挥复杂的作用. 抑制GREM1可以破坏瘤生长,突出其作为治疗点的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 格雷姆林-1 (GREM1) 是一种在恶性瘤中高度表达的骨形态蛋白 (BMP) 抗剂.
- 由于瘤微环境 (TME) 的异质性,GREM1在癌症中的作用是复杂和有争议的.
- GREM1通过BMP依赖和独立的途径影响TME,影响瘤的进展.
研究的目的:
- 审查通过TME中的GREM1调节关键癌症过程的信号通路.
- 阐明GREM1在表皮-介质细胞过渡 (EMT),瘤免疫微环境 (TME) 构建和癌症干性中的作用.
- 总结一下GREM1作为治疗点的当前临床进展.
主要方法:
- 关于格雷姆林-1 (GREM1) 和其在瘤微环境 (TME) 中的作用的文献综述.
- 通过GREM1.1调节的BMP依赖和独立信号通路的分析.
- 综合有关GREM1对EMT,免疫微环境和癌症干性的影响的信息.
主要成果:
- GREM1通过BMP依赖和独立的机制调节EMT,瘤免疫微环境和癌症干性.
- 瘤细胞和纤维细胞交叉影响GREM1分泌,影响GREM1/BMP平衡和瘤进展.
- 抑制GREM1活动会破坏支持瘤的微环境,表明治疗潜力.
结论:
- GREM1是瘤微环境和癌症进展的关键调节者.
- 调节GREM1活动为各种恶性瘤提供了一个有前途的治疗策略.
- 需要对GREM1向疗法的进一步临床研究.
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:38Mitogens and the Cell Cycle
6.4K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
03:03mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K